Peter Valent
Hat mitgewirkt an:
-
Identification of a leukemia-initiating stem cell in human mast cell leukemia
-
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study
-
Clonal medicine targeting DNA damage response eradicates leukemia
-
15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives